Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Alagpulinsa

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|November 18, 2014
A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to DoxorubicinDavid A Alagpulinsa, Srinivas Ayyadevara, Robert Joseph Shmookler Reis
Molecular Cancer Therapeutics|January 1, 2016
A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP InhibitionDavid A Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby, et al.
Trends in Molecular Medicine|March 28, 2022
Advances in understanding the molecular basis of clonal hematopoiesisDavid A Alagpulinsa, Mabel P Toribio, Iad Alhallak, et al.
Pharmacology & Therapeutics|August 28, 2018
Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetesDavid A Alagpulinsa, Jenny J L Cao, Don Sobell, et al.
Diabetologia|August 14, 2024
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte countsJolade Adebekun, Ajay Nadig, Priscilla Saarah, et al.
Trends in Cancer|June 4, 2020
Genomic Instability in Multiple MyelomaDavid A Alagpulinsa, Raphael E Szalat, Mark C Poznansky, et al.
Blood Advances|December 6, 2019
Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myelomaDavid A Alagpulinsa, Subodh Kumar, Srikanth Talluri, et al.
Biomaterials|December 11, 2020
Metabolomic and transcriptomic analyses of the anti-rheumatoid arthritis potential of xylopic acid in a bioinspired lipoprotein nanoformulationRaphael N Alolga, Yaw Opoku-Damoah, David A Alagpulinsa, et al.
Nature Communications|March 14, 2026
Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traitsPriscilla Saarah, Zehra A Syeda, Ziang Xu, et al.
Xenotransplantation|December 23, 2025
Pilot Study: Functional Survival of Human Stem Cell-Derived Islets Microencapsulated With Alginate Incorporating CXCL12 in Non-Human Primates Without Systemic ImmunosuppressionKento Kawai, Fatma Dogan, David A Alagpulinsa, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|November 18, 2014
A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to DoxorubicinDavid A Alagpulinsa, Srinivas Ayyadevara, Robert Joseph Shmookler Reis
Molecular Cancer Therapeutics|January 1, 2016
A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP InhibitionDavid A Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby, et al.
Trends in Molecular Medicine|March 28, 2022
Advances in understanding the molecular basis of clonal hematopoiesisDavid A Alagpulinsa, Mabel P Toribio, Iad Alhallak, et al.
Pharmacology & Therapeutics|August 28, 2018
Harnessing CXCL12 signaling to protect and preserve functional β-cell mass and for cell replacement in type 1 diabetesDavid A Alagpulinsa, Jenny J L Cao, Don Sobell, et al.
Diabetologia|August 14, 2024
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte countsJolade Adebekun, Ajay Nadig, Priscilla Saarah, et al.
Trends in Cancer|June 4, 2020
Genomic Instability in Multiple MyelomaDavid A Alagpulinsa, Raphael E Szalat, Mark C Poznansky, et al.
Blood Advances|December 6, 2019
Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myelomaDavid A Alagpulinsa, Subodh Kumar, Srikanth Talluri, et al.
Biomaterials|December 11, 2020
Metabolomic and transcriptomic analyses of the anti-rheumatoid arthritis potential of xylopic acid in a bioinspired lipoprotein nanoformulationRaphael N Alolga, Yaw Opoku-Damoah, David A Alagpulinsa, et al.
Nature Communications|March 14, 2026
Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traitsPriscilla Saarah, Zehra A Syeda, Ziang Xu, et al.
Xenotransplantation|December 23, 2025
Pilot Study: Functional Survival of Human Stem Cell-Derived Islets Microencapsulated With Alginate Incorporating CXCL12 in Non-Human Primates Without Systemic ImmunosuppressionKento Kawai, Fatma Dogan, David A Alagpulinsa, et al.
Pageof 2